Monoclonal antibodies (mAbs) are laboratory-made proteins that are designed to mimic the immune system's ability to fight off harmful pathogens such as viruses and cancer cells. Since the approval of the first monoclonal antibody drug, Orthoclone OKT3, in 1986, monoclonal antibodies have revolutionized the treatment of various diseases, including cancer, autoimmune disorders, and infectious...